Conference
FRACTION-RCC: innovative, high-throughput assessment of nivolumab plus ipilimumab (N plus I) for treatment-refractory advanced renal cell carcinoma (aRCC)
Authors
Loidl W; Choueiri TK; Kluger H; George S; Tykodi SS; Kuzel TM; Perets R; Nair S; Procopio G; Carducci M
Volume
43
Pagination
pp. 209-209
Publisher
KARGER
Publication Date
October 1, 2020
Conference proceedings
ONCOLOGY RESEARCH AND TREATMENT
Issue
SUPPL 4
ISSN
2296-5270